Glucose decreases steady state mRNA content of hydrophobic surfactant proteins B and C in fetal rat lung explants

Experimental Lung Research

Volumn 25, Issue 1, 1999, Pages 69-79

  Rayani, Hamid H ^a   Gewolb, Ira H ^b   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose; Infant of diabetic pregnancy; Northern blot; Surfactant protein mRNA

Indexed keywords

GLUCOSE; MESSENGER RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; EXPLANT; FEMALE; GENE EXPRESSION; HYDROPHOBICITY; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; NONHUMAN; NORTHERN BLOTTING; PREGNANCY; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL;

ANIMALS; AUTORADIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; LUNG; ORGAN CULTURE TECHNIQUES; PREGNANCY; PROTEOLIPIDS; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0033031057     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021499270439     Document Type: Article

References (40)

1. Floros J, Phelps DS: Pulmonary surfactant. In: Biebuyck J, Lynch C III, Maze M, Saidman LJ, Yaksh TL, and Zapol WM, eds. Anesthesia: Biologic Foundations. Philadelphia: Lippincott-Raven Press. 1997;1257-1279.
2. Avery ME, Mead J: Surface properties in relation to atelectases and hyaline membrane disease. Am J Dis Child. 1959;97:517-523.
3. Bourbon JR, Farrell PM: Fetal lung development in the diabetic pregnancy. Pediatr Res. 1985;19:253-267.
4. James DK, Chiswick ML, Harkes A, Williams M, Tindall VR: Maternal diabetes and neonatal respiratory distres. I. Maturation of fetal surfactant. Br J Obstet Gynecol. 1984;91:316-324.
5. Robert MF, Neff RK, Hubbell JP, Tacusch HW, Avery ME: Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med. 1976;294:357-360.
6. Katyal SL, Amenta JS, Singh G, Silverman, JA: Deficient lung surfactant apoproteins in amniotic fluid with mature phospholipid profile from diabetic pregnancies. Am J Obstet Gynecol. 1984;148:48-53.
7. Snyder JM, Kwan JE, O'Brien JA, Rosenfield, Odom MJ: The concentration of the 35 kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res. 1988;24:728-734.
8. Petersen J: Weight and length at birth of infants of the diabetic mothers. Acta Endocrinol. 1954;16:330-342.
9. Bourbon JR, Pignol B, Marin L, Rieutort M, Tordet C: Maturation of fetal rat lung in diabetic pregnancies of graduated severity. Diabetes. 1985;34:734-743.
10. Gewolb IH, Barrett C, Wilson DM, Warshaw JB: Delay in pulmonary glycogen degradation in fetuses of streptozotocin diabetic rats. Pediatr Res 1982;16:869-873.
11. Gewolb IH, Rooney SA, Barrett C, Ingleson LD, Light D, Wilson CM, Smith GJW, Gross I, Warshaw JB: Delayed pulmonary maturation in the fetus of the streptozotoxin diabetic rat. Exp Lung Res. 1958;8:141-151.
12. Guttentag SH, Phelps DS, Stenzel W, Warshaw JB, Floros J: Surfactant protein-A expression is delayed in fetuses of streptozotocin treated rats. Am J Physiol. 1992;262(Lung Cell Mol Physiol 6):L489-L494.
13. Guttentag SH, Phelps DS, Warshaw JB, Floros J: Delayed hydrophobic surfactant protein (SP-B, SP-C) expression in fetuses of streptozotocin treated rats. Am J Respir Cell Mol Biol. 1992;7:190-197.
14. Rayani HH, Warshaw JB, Floros J: Dexamethasone enhances surfactant protein gene expression in streptozotocin-induced immature rat lungs. Pediatr Res. 1995;38:870-877.
15. Gewolb IH: High glucose causes delayed fetal lung maturation in vitro. Exp Lung Res. 1993;19:619-630.
16. Gewolb IH, Torday JS: High glucose inhibits maturation of the fetal lung in vitro: morphometric analysis or lamellar bodies and fibroblast lipid inclusions. Lab Invest. 1995;73:1-5.
17. Warburton D: Chronic hyperglycemia reduces surface active material flux in tracheal fluid of fetal lambs. J Clin Invest. 1983;71:550-555.
18. Gewolb IH, O'Brien J: Inhibition of synthesis and secretion of surfactant in fetal rat lung type II pneumocytes of high glucose concentrations. Exp Lung Res. 1997;23:245-255.
19. Mendelson CR, Johnston JM, MacDonald PC, Snyder JM: Multihormonal regulation of surfactant synthesis by human fetal lung in vitro. J Clin Endocrinol Metab. 1981;53:307-317.
20. Snyder JM, Longmuir KJ, Johnson JM, Mendelson CR: Hormonal regulation of the synthesis of lamellar body phosphatidylglycerol and phosphatidylinositol in fetal lung tissue. Endocrinology. 1983;112:1012-1018.
21. Snyder JM, Mendelson CR: Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro. Endocrinology. 1987;120:1250-1257.
22. Dekowski SA, Snyder JM: Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology. 1992;131:669-676.
23. Gross I, Smith GJW, Maniscalco WM, Wilson CM, Rooney SA: An organ culture model for study of biochemical development of fetal rat lung. J Appl Physiol. 1978;45:355-362.
24. Gewolb IH: Effect of high glucose on fetal lung maturation at different times during late gestation. Exp Lung Res. 1996;22:201-211.
25. Moglia BA, Phelps DS: Changes in surfactant protein A mRNA levels in a rat model of insulin-treated diabetic pregnancy. Pediatr Res. 1996;39-241-247.
26. Nichols VK, Floros J, Dynia DW, Veletza SV, Wilson CM, Gross I: Regulation of surfactant protein A (SP-A) mRNA by hormones and butyrate in cultured fetal rat lung. Am j Physiol. 1990;259(Lung Cell Mol Physiol 3):L488-L495.
27. Floros J, Gross I, Nichols KV, Veletza SV, Dynia D, Lu H, Wilson CM, Peterec SM: Hormonal effects on the surfactant protein B (SP-B) mRNA in alveolar and bronchiolar epithelium. Am J Respir Cell Mol Biol 1991;4:449-454.
28. Veletza SV, Nichols KV, Gross I, Lu H, Dynia DW, Floros J: Surfactant protein C: hormonal control of SP-C mRNA levels in vitro. Am J Physiol. 1992;262(Lung Cell Mol Physiol 6):L684-L687.
29. Peterec SM, Nichols KV, Dynia DW, Wilson CM, Gross I: Butyrate modulates surfactant protein mRNA in fetal rat lung by altering mRNA transcription and stability. Am J Physiol. 1994;267(Lung Cell Mol Physiol. 11):L9-L15.
30. Perrine SP, Miller BA, Greene MF, Cohen RA, Cook N, Shackleton C, Faller DV: Butyric acid analogues augment gamma globin gene expression in neonatal erythroid precursors. Biochem Biophys Res Commun. 1987;148:694-700.
31. Foufelle F, Girard J, Ferre P: Regulation of lipogenic enzyme expression by glucose in liver and adipose tissue: a review of the potential cellular and molecular mechanisms. Adv Enzyme Regulation. 1996;36:199-226.
32. Haugel-de-Mouzon S, Mrejen C, Alengrin F, Van Obberghen E: Glucose-induced stimulation of human insulin-receptor mRNA and tyrosine kinase activity in cultured cells. Biochem J. 1995;305:119-124.
33. Rencurel F, Waeber G, Antoine B, Rocchiccioli F, Maulard P, Girard J Leturque A: Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. Biochem J. 1996;314:903-909.
34. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P: High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney International. 1994;46:105-112.
35. Kreisberg JI, Garoni J, Radnik RA, Ayo SH: High glucose and TGF beta 1 stimulate fibronectin gene expression through a cAMP response element. Kidney International. 1994;46:1019-1024.
36. Shankland SJ, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney International. 1995;47:782-788.
37. Conestino F, Hishikawa K, Katusic ZS, Lusher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96:25-28.
38. Tseng CC, Jorboe LA, Wolfe MM: Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal. Am J Physiol. 1994;266:G887-G891.
39. Zmora E, Gewolb IH, Shapiro DL: Effects of insulin and glucose on pulmonary insulin receptors in late gestation fetal rats. Exp Lung Res. 1992;18:247-258.
40. Gewolb IH, O'Brien J, Palese T, Phillip M: High glucose and insulin decrease fetal lung insulin receptor mRNA and tyrosine kinase activity in vitro. Biochem Biophys Res Commun. 1994;202:694-700.